Tue, November 14, 2023

David Amsellem Downgraded (CARA) to Hold and Decreased Target to $1 on, Nov 14th, 2023

David Amsellem of Piper Sandler, Downgraded "Cara Therapeutics, Inc." (CARA) to Hold and Decreased Target from $12 to $1 on, Nov 14th, 2023.

David has made no other calls on CARA in the last 4 months.



There are 2 other peers that have a rating on CARA. Out of the 2 peers that are also analyzing CARA, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $7 on, Thursday, October 19th, 2023
  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $22 on, Tuesday, August 8th, 2023